BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 34173832)

  • 1. Association of Medication-Assisted Treatment and Age With Treatment Completion Among Veterans Seeking Non-VA Treatment for Opioid use Disorder at Non-Veterans Health Administration Facilities.
    Pickard JG; van den Berk-Clark C; Matthieu MM
    Mil Med; 2022 Mar; 187(3-4):504-512. PubMed ID: 34173832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the impact of an opioid-specific education series on rates of medication-assisted treatment for opioid use disorder in veterans.
    Kirby T; Connell R; Linneman T
    Am J Health Syst Pharm; 2021 Feb; 78(4):301-309. PubMed ID: 33289022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid use and opioid use disorder in mono and dual-system users of veteran affairs medical centers.
    Goulet J; Cheng Y; Becker W; Brandt C; Sandbrink F; Workman TE; Ma P; Libin A; Shara N; Spevak C; Kupersmith J; Zeng-Treitler Q
    Front Public Health; 2023; 11():1148189. PubMed ID: 37124766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medication-assisted treatment and self-help group participation among military veterans with opioid or alcohol use disorder.
    Albright DL; McDaniel JT; Suntai Z; Laha-Walsh MK; Frick K; Weatherly T; McIntosh S
    BMJ Mil Health; 2023 Jun; 169(3):256-262. PubMed ID: 34253642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of age and opioid agonist treatment on substance use treatment completion in the United States.
    van den Berk Clark C; Pickard JG; Drallmeier T
    Aging Ment Health; 2022 Jun; 26(6):1295-1302. PubMed ID: 33999741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Community Treatment for Opioid Use Disorders in Urban and Rural Veterans.
    Turvey CL; Lund BC; Jones D; Arndt S
    J Rural Health; 2020 Mar; 36(2):167-176. PubMed ID: 31808589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual Receipt of Prescription Opioids From the Department of Veterans Affairs and Medicare Part D and Prescription Opioid Overdose Death Among Veterans: A Nested Case-Control Study.
    Moyo P; Zhao X; Thorpe CT; Thorpe JM; Sileanu FE; Cashy JP; Hale JA; Mor MK; Radomski TR; Donohue JM; Hausmann LRM; Hanlon JT; Good CB; Fine MJ; Gellad WF
    Ann Intern Med; 2019 Apr; 170(7):433-442. PubMed ID: 30856660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fall-related Injuries and Opioid Administration Among Veterans With Dementia in US Department of Veterans Affairs Community Living Centers.
    Wang H; Cai S; Caprio T; Goulet J; Intrator O
    Med Care; 2023 Sep; 61(9):579-586. PubMed ID: 37476853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polysubstance use and association with opioid use disorder treatment in the US Veterans Health Administration.
    Lin LA; Bohnert ASB; Blow FC; Gordon AJ; Ignacio RV; Kim HM; Ilgen MA
    Addiction; 2021 Jan; 116(1):96-104. PubMed ID: 32428386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations between Medication Assisted Therapy Services Delivery and Mortality in a National Cohort of Veterans with Posttraumatic Stress Disorder and Opioid Use Disorder.
    Riblet NB; Gottlieb DJ; Shiner B; Cornelius SL; Watts BV
    J Dual Diagn; 2020; 16(2):228-238. PubMed ID: 31852392
    [No Abstract]   [Full Text] [Related]  

  • 11. Stepped Care for Opioid Use Disorder Train the Trainer (SCOUTT) initiative: Expanding access to medication treatment for opioid use disorder within Veterans Health Administration facilities.
    Gordon AJ; Drexler K; Hawkins EJ; Burden J; Codell NK; Mhatre-Owens A; Dungan MT; Hagedorn H
    Subst Abus; 2020; 41(3):275-282. PubMed ID: 32697170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Retrospective 4-year Outcome Study of Veterans Admitted to an Acute Inpatient Detoxification Unit for Opioid Use Disorder.
    Li KJ; Smedberg DL; DeLisi LE
    Am J Addict; 2019 Jul; 28(4):318-323. PubMed ID: 31067001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-acting intramuscular naltrexone for opioid use disorder: Utilization and association with multi-morbidity nationally in the Veterans Health Administration.
    Kelly MM; Reilly E; QuiƱones T; Desai N; Rosenheck R
    Drug Alcohol Depend; 2018 Feb; 183():111-117. PubMed ID: 29245103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing Quality of Care in Veterans Affairs and Non-Veterans Affairs Settings.
    Anhang Price R; Sloss EM; Cefalu M; Farmer CM; Hussey PS
    J Gen Intern Med; 2018 Oct; 33(10):1631-1638. PubMed ID: 29696561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changing Trends in Opioid Overdose Deaths and Prescription Opioid Receipt Among Veterans.
    Lin LA; Peltzman T; McCarthy JF; Oliva EM; Trafton JA; Bohnert ASB
    Am J Prev Med; 2019 Jul; 57(1):106-110. PubMed ID: 31128955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual Use of Department of Veterans Affairs and Medicare Benefits on High-Risk Opioid Prescriptions in Veterans Aged 65 Years and Older: Insights from the VA Musculoskeletal Disorders Cohort.
    Chui PW; Bastian LA; DeRycke E; Brandt CA; Becker WC; Goulet JL
    Health Serv Res; 2018 Dec; 53 Suppl 3(Suppl Suppl 3):5402-5418. PubMed ID: 30298672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duration of opioid prescriptions predicts incident nonmedical use of prescription opioids among U.S. veterans receiving medical care.
    Barry DT; Marshall BDL; Becker WC; Gordon AJ; Crystal S; Kerns RD; Gaither JR; Gordon KS; Justice AC; Fiellin DA; Edelman EJ
    Drug Alcohol Depend; 2018 Oct; 191():348-354. PubMed ID: 30176548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tracking implementation strategies in the randomized rollout of a Veterans Affairs national opioid risk management initiative.
    Rogal SS; Chinman M; Gellad WF; Mor MK; Zhang H; McCarthy SA; Mauro GT; Hale JA; Lewis ET; Oliva EM; Trafton JA; Yakovchenko V; Gordon AJ; Hausmann LRM
    Implement Sci; 2020 Jun; 15(1):48. PubMed ID: 32576214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medication for opioid use disorder treatment and specialty outpatient substance use treatment outcomes: Differences in retention and completion among opioid-related discharges in 2016.
    Askari MS; Martins SS; Mauro PM
    J Subst Abuse Treat; 2020 Jul; 114():108028. PubMed ID: 32527510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receipt of Overlapping Opioid and Benzodiazepine Prescriptions Among Veterans Dually Enrolled in Medicare Part D and the Department of Veterans Affairs: A Cross-sectional Study.
    Carico R; Zhao X; Thorpe CT; Thorpe JM; Sileanu FE; Cashy JP; Hale JA; Mor MK; Radomski TR; Hausmann LRM; Donohue JM; Suda KJ; Stroupe K; Hanlon JT; Good CB; Fine MJ; Gellad WF
    Ann Intern Med; 2018 Nov; 169(9):593-601. PubMed ID: 30304353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.